Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bifunctional epoxide hydrolase 2 | ||
Ligand | BDBM50217444 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_444681 (CHEMBL894930) | ||
IC50 | 0.6±n/a nM | ||
Citation | Hwang, SH; Tsai, HJ; Liu, JY; Morisseau, C; Hammock, BD Orally bioavailable potent soluble epoxide hydrolase inhibitors. J Med Chem50:3825-40 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Bifunctional epoxide hydrolase 2 | |||
Name: | Bifunctional epoxide hydrolase 2 | ||
Synonyms: | Cytosolic epoxide hydrolase 2 | EBifunctional epoxide hydrolase 2 | EPHX2 | Epoxide hydratase | HYES_HUMAN | Lipid-phosphate phosphatase | Soluble epoxide hydrolase (sEH) | epoxide hydrolase 2, cytoplasmic | ||
Type: | Enzyme | ||
Mol. Mass.: | 62613.07 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P34913 | ||
Residue: | 555 | ||
Sequence: |
| ||
BDBM50217444 | |||
n/a | |||
Name | BDBM50217444 | ||
Synonyms: | CHEMBL244002 | cis-4-{4-[3-(4-trifluoromethoxyphenyl)ureido]cyclohexyloxy}-benzoic acid | ||
Type | Small organic molecule | ||
Emp. Form. | C21H21F3N2O5 | ||
Mol. Mass. | 438.397 | ||
SMILES | OC(=O)c1cccc(O[C@@H]2CC[C@@H](CC2)NC(=O)Nc2ccc(OC(F)(F)F)cc2)c1 |wU:12.15,9.8,(29.99,.67,;30.71,2.03,;32.25,2.08,;29.89,3.33,;30.61,4.69,;29.79,6,;28.25,5.94,;27.54,4.58,;26,4.53,;25.28,3.17,;23.74,3.11,;23.01,1.74,;23.83,.45,;25.38,.5,;26.09,1.86,;23.12,-.91,;21.58,-.97,;20.75,.33,;20.86,-2.34,;19.32,-2.4,;18.51,-1.09,;16.97,-1.15,;16.25,-2.52,;14.71,-2.58,;13.89,-1.28,;13.11,.06,;12.57,-2.08,;15.21,-.49,;17.08,-3.83,;18.62,-3.76,;28.35,3.28,)| | ||
Structure |